مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

video

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

sound

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Persian Version

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

View:

211
مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Download:

118
مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Cites:

Information Journal Paper

Title

Osteopontin and Angiogenic Factors as New Biomarkers of Prostate Cancer

Pages

  134-140

Abstract

 Purpose: The novel biomarkers that would identify patients at risk for relapse and metastatic spread are needed. The aim of this study was the evaluation of serum levels of osteopontin (OPN) and tumor endogenous angiogenic factors such as vascular– endothelial growth factor (VEGF), vascular-endothelial growth factor receptor 2 (VEGF R2), endostatin, angiostatin and thrombospondin 1, in prostate cancer (PC) patients. Material and Methods: Blood concentrations of the analyzed parameters were determined in 40 prostate cancer patients eligible for radiotherapy as well as in a control group consisting of 25 volunteers. Commercial ELISA kits were used for the analysis. Results: Significantly higher levels of OPN (101. 49 ng/mL vs 59. 88 ng/mL; P <. 001), endostatin (252. 60 ng/ mL vs. 223. 55 ng/mL; P =. 043), angiostatin (47 ng/mL vs. 13 ng/mL; P =. 047), VEGF (262. 1 pg/mL vs. 138. 0 pg/mL; P =. 056) and VEGF R2 (11188. 81 pg/mL vs. 9377. 50 pg/mL; P =. 047) were detected in PC patients compared with the control group. In PC patients we showed a positive correlation between OPN level and TNM clinical stage (R = 0. 36; P =. 02) and negative correlation between OPN level and hemoglobin concentration (R=-0. 33; P =. 04). Conclusion: The study showed higher levels of the angiogenic factors in PC patients compared with the control group and identified OPN as an indicator of the PC clinical stage as well as a decreased hemoglobin level.

Cites

  • No record.
  • References

    Cite

    APA: Copy

    Wisniewski, Tomasz, zyromska, Agnieszka, Makarewicz, Roman, & zekanowska, Ewa. (2019). Osteopontin and Angiogenic Factors as New Biomarkers of Prostate Cancer. UROLOGY JOURNAL, 16(2), 134-140. SID. https://sid.ir/paper/271528/en

    Vancouver: Copy

    Wisniewski Tomasz, zyromska Agnieszka, Makarewicz Roman, zekanowska Ewa. Osteopontin and Angiogenic Factors as New Biomarkers of Prostate Cancer. UROLOGY JOURNAL[Internet]. 2019;16(2):134-140. Available from: https://sid.ir/paper/271528/en

    IEEE: Copy

    Tomasz Wisniewski, Agnieszka zyromska, Roman Makarewicz, and Ewa zekanowska, “Osteopontin and Angiogenic Factors as New Biomarkers of Prostate Cancer,” UROLOGY JOURNAL, vol. 16, no. 2, pp. 134–140, 2019, [Online]. Available: https://sid.ir/paper/271528/en

    Related Journal Papers

  • No record.
  • Related Seminar Papers

  • No record.
  • Related Plans

  • No record.
  • Recommended Workshops






    Move to top
    telegram sharing button
    whatsapp sharing button
    linkedin sharing button
    twitter sharing button
    email sharing button
    email sharing button
    email sharing button
    sharethis sharing button